Summary

for females ages 18 years and up (full criteria)
healthy people welcome
at UCLA
study started
estimated completion
Aparna Sridhar (ucla)

Description

Summary

Virtual reality (VR) has been used in health care settings to decrease anxiety and pain. This project is a feasibility study to evaluate whether virtual reality can be used in the setting of a first trimester pregnancy termination by D&C and whether the use of virtual reality (VR) headsets can help decrease anxiety for patients during this procedure.

Official Title

Feasibility of an Immersive Virtual Reality Intervention for First Trimester D&C: A Pilot Study

Details

The investigators will assess the practicality and qualitative experience of women using VR during first trimester surgical abortion under local anesthesia. Semi-structured interviews will be conducted to understand the patient's experience of using VR. Surveys evaluating anxiety will be administered to women before and after surgical abortion. Investigators plan to enroll 30 patients in order to obtain an effect size for future studies. A group of control patients will be enrolled; these patients will receive standard care and will be compared to the anxiety scores of the group receiving VR. The mean and standard deviation of anxiety scores for each group will be used to calculate power for future studies.

Keywords

First Trimester Abortion Virtual Reality Anxiety applied VR headset

Eligibility

You can join if…

Open to females ages 18 years and up

  • Age 18 or over
  • Elective surgical abortion under local anesthesia
  • English speaker

You CAN'T join if...

  • No psychiatric history
  • No history of motion sickness or vertigo
  • No history of seizures or epilepsy
  • No recent eye surgery or visual impairment
  • No claustrophobia.
  • No current nausea or vomiting
  • Not on seizure-threshold lowering medications

Location

  • University of California Los Angeles Obstetrics and Gynecology Clinic
    Los Angeles California 90024 United States

Lead Scientist

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Los Angeles
ID
NCT03533036
Study Type
Interventional
Last Updated